L-DOPA and the Pathways of Melanins. The amino acid L-DOPA (30, see chapter 7.5.1) plays a central intermediate stage in catecholamine biosynthesis. It is still the most important drug for the treatment of Parkinson's disease to this day.
L-DOPA (30) also plays a key role in skin pigmentation. As can be seen from the following diagram, via DOPA quinone (33) on the one hand dopachrome (34) and on the other hand thio derivatives (35 and 36) of the L- DOPA (30), which cyclize to benzothiazines (37 and 38). Polymers that arise from it are called
